SPRINGFIELD – State Senator Julie Morrison passed a law to bring more diversity to clinical cancer trials.

“Increasing the diversity of those participating in clinical cancer trials will have a positive impact on the ability to study how the trial treatments might affect a wider segment of the population,” said Morrison (D-Lake Forest). “This law will pave the way for higher participation from historically underrepresented communities.”

Under the new law, the Illinois Department of Public Health will work with the University of Illinois and other relevant organizations to conduct a study examining what demographics are currently underrepresented in clinical trials, identify barriers to participation and pinpoint ways to improve outreach to these communities. IDPH will report the findings of this study to the General Assembly by July 1, 2026, as well as establish a website with relevant information from the study.

“This law is one of many I have championed to improve cancer treatment and research,” said Morrison. “Cancer fatalities have fallen in the past 30 years and I am committed to continuing that downward trajectory.”

House Bill 5405 was signed into law Friday and goes into effect Jan. 1, 2025.